Loading...
Rockwell Medical, Inc.
RMTI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.13
$-0.16(-12.40%)
Rockwell Medical, Inc. (RMTI) Financial Performance & Statements
Review Rockwell Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
21.38%
↑ 21.38%
Operating Income Growth
109.12%
↑ 109.12%
Net Income Growth
94.31%
↑ 94.31%
Operating Cash Flow Growth
144.65%
↑ 144.65%
Operating Margin
0.59%
↑ 0.59%
Gross Margin
17.87%
↑ 17.87%
Net Profit Margin
-0.27%
↓ 0.27%
ROE
-0.90%
↓ 0.90%
ROIC
1.34%
↑ 1.34%
Rockwell Medical, Inc. (RMTI) Financial Statements
Explore quarterly and annual reports for Rockwell Medical, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $24.66M | $28.32M | $25.83M | $22.68M |
| Cost of Revenue | $21.03M | $22.08M | $21.28M | $19.61M |
| Gross Profit | $3.63M | $6.24M | $4.55M | $3.06M |
| Gross Profit Ratio | $0.15 | $0.22 | $0.18 | $0.14 |
| R&D Expenses | $1000.00 | $0.00 | $0.00 | $18000.00 |
| SG&A Expenses | $4.15M | $4.30M | $4.04M | $4.37M |
| Operating Expenses | $4.15M | $4.30M | $4.04M | $4.39M |
| Total Costs & Expenses | $25.18M | $26.38M | $25.32M | $24.00M |
| Interest Income | $29000.00 | $30000.00 | $9000.00 | $24000.00 |
| Interest Expense | $289000.00 | $302000.00 | $232000.00 | $431000.00 |
| Depreciation & Amortization | $543000.00 | $543000.00 | $549000.00 | $545000.00 |
| EBITDA | $75000.00 | $2.51M | $1.12M | -$755000.00 |
| EBITDA Ratio | $0.003 | $0.09 | $0.04 | -$0.03 |
| Operating Income | -$519000.00 | $1.94M | $515000.00 | -$1.32M |
| Operating Income Ratio | -$0.02 | $0.07 | $0.02 | -$0.06 |
| Other Income/Expenses (Net) | -$237000.00 | -$272000.00 | -$172000.00 | -$407000.00 |
| Income Before Tax | -$756000.00 | $1.66M | $343000.00 | -$1.73M |
| Income Before Tax Ratio | -$0.03 | $0.06 | $0.01 | -$0.08 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$545000.00 |
| Net Income | -$756000.00 | $1.66M | $343000.00 | -$1.73M |
| Net Income Ratio | -$0.03 | $0.06 | $0.01 | -$0.08 |
| EPS | -$0.03 | $0.05 | $0.009 | -$0.06 |
| Diluted EPS | -$0.03 | $0.05 | $0.009 | -$0.06 |
| Weighted Avg Shares Outstanding | $32.88M | $31.55M | $30.45M | $29.33M |
| Weighted Avg Shares Outstanding (Diluted) | $32.88M | $32.42M | $32.03M | $29.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan